Marex Group plc Stock Price, News & Analysis

Marex (NASDAQ: MRX) launched its US structured products business on Nov 19, 2025 to serve RIAs, broker‑dealers, and private banks seeking issuer and credit diversification. The US unit is led by Scott Kerbel, Head of US Distribution, and will draw on Marex’s global business that has issued more than 20,000 structured products. Marex positions itself as a non-bank issuer offering faster turnaround and transparent pricing while citing a US structured-products market on track for $220bn in 2025. The firm plans a broad range of tailored solutions and expanded US coverage to deepen relationships with financial advisors and private banks.

Marex Group (Nasdaq: MRX) reported Q3 2025 results on November 6, 2025: Q3 revenue $484.6m (+24% year‑on‑year) and Adjusted Profit Before Tax $100.5m (+25% y/y). Q3 YTD revenue was $1,452.0m (+23%) and Adjusted PBT YTD $303.2m (+26%).

Key drivers included Clearing (average client balances $13.3bn, +4%), a 52% rise in Agency and Execution revenue, Prime Services expansion, and record Hedging & Investment Solutions trading. Reported costs rose 24% to $380.3m. The board declared a $0.15 per‑share Q3 dividend; S&P reaffirmed an investment‑grade credit rating on September 23, 2025.

Marex Group (NASDAQ: MRX) will release its fiscal 2025 third quarter results before market open on Thursday, November 6, 2025. The earnings release and supplementary materials will be posted in the Investors section of the Marex website at https://ir.marex.com/.

A live conference call to discuss the results is scheduled for 9:00 AM ET on November 6, 2025; live access is available via the provided webcast link. Contact details for investor enquiries and PR advisors are included in the announcement.

Marex Group (NASDAQ: MRX) agreed to acquire Geneva-based fixed income market maker Valcourt SA, adding 700 clients and specialist capabilities in high-yield, subordinated, emerging markets, private, illiquid and sustainable debt.

The transaction aims to expand Marex’s fixed income distribution into the Swiss institutional community and diversify earnings by offering Valcourt clients access to Marex’s broader platform. The deal is subject to regulatory approval and is expected to close in the first half of 2026.

Marex (NASDAQ: MRX) announced that directors and officers purchased ordinary shares in the open market between October 10–14, 2025. Key purchases include CEO Ian Lowitt buying 32,465 shares (total 2,615,016), Paolo Tonucci buying 30,000 shares (total 1,108,342), Non-Executive Chairman Robert Pickering buying 2,700 shares (total 20,594) and Board member Konstantin Graf von Schweinitz buying 7,100 shares (total 14,993). Former board members Sir Jeremy Isaacs and Roger Nagioff each bought 35,000 shares.

Management says the purchases reflect confidence in Marex’s growth trajectory and notes the executive leadership team collectively owns more than 7% of the company.

Marex (NASDAQ: MRX) announced on October 13, 2025 that Chief Executive Officer Ian Lowitt purchased 32,465 ordinary shares in the open market on October 10, 2025, increasing his total holding to 2,615,016 ordinary shares.

The transaction was an open‑market purchase by the CEO and updates insider ownership levels disclosed by the company.